Bragar Eagel & Squire, P.C. is Investigating Akers Biosciences, Inc. (AKER) on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)--Jun 13, 2018--Bragar Eagel & Squire, P.C. is investigating potential claims against Akers Biosciences, Inc. (NASDAQ: AKER). Our investigation concerns whether Akers Biosciences has violated the federal securities laws and/or engaged in other unlawful business practices.
On May 21, 2018, Akers revealed that it would delay filing its Form 10-Q with the SEC for the quarter ended March 31, 2018 and will continue reviewing the “characterization of certain revenue recognition items” which “now includes certain transactions in previous quarters.” Following this news, Akers stock dropped $0.058 per share, or over 8%, to close at $0.599 per share on May 22, 2018.
Then, on May 29, 2018, Akers issued a press release stating that “Raymond F. Akers Jr., Ph.D. has resigned as a director of the Company with immediate effect.” Following this announcement, shares of Akers fell $0.198 or over 33% to close at $0.391 per share on May 29, 2018.
On June 1, 2018, Akers filed a letter with the SEC from Raymond Akers which stated that Dr. Akers “resigned from the Board of Directors due to significant differences regarding the policies and practices of the Board of Directors, accounting and business practices of Management, and new Counsel.”
If you purchased or otherwise acquired Akers Biosciences shares and suffered a loss, continue to hold shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Akers Biosciences, Inc., please go to http://www.bespc.com/akers. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180613006177/en/
CONTACT: Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL
SOURCE: Bragar Eagel & Squire, P.C.
Copyright Business Wire 2018.
PUB: 06/13/2018 03:56 PM/DISC: 06/13/2018 03:56 PM